AZT treatment induces molecular and ultrastructural oxidative damage to muscle mitochondria. Prevention by antioxidant vitamins

The Journal of Clinical Investigation
José García de la AsunciónJ Viña

Abstract

AIDS patients who receive zidovudine (AZT) frequently suffer from myopathy. This has been attributed to mitochondrial (mt) damage, and specifically to the loss of mtDNA. This study examines whether AZT causes oxidative damage to DNA in patients and to skeletal muscle mitochondria in mice, and whether this damage may be prevented by supranutritional doses of antioxidant vitamins. Asymptomatic HIV-infected patients treated with AZT have a higher urinary excretion (355+/-100 pmol/kg/d) of 8-oxo-7, 8-dihydro-2'-deoxyguanosine (8-oxo-dG) (a marker of oxidative damage to DNA) than untreated controls (asymptomatic HIV-infected patients) (182+/-29 pmol/kg/d). This was prevented (110+/-79 pmol/kg/d) by simultaneous oral treatment with AZT plus antioxidant vitamins (C and E). Mice treated with AZT also had a significantly higher urinary excretion of 8-oxo-dG than controls. Skeletal muscle mtDNA of mice treated with AZT had more 8-oxo-dG than controls. mt lipoperoxidation was also increased and skeletal muscle glutathione was oxidized. These effects may be due to an increased peroxide production by muscle mitochondria of AZT-treated animals. Dietary supplements with vitamins C and E at supranutritional doses protect against oxidative dama...Continue Reading

References

Dec 1, 1975·Analytical Biochemistry·J M Gutteridge
Jan 1, 1992·Free Radical Biology & Medicine·H Kappus, A T Diplock
Apr 15, 1991·Biochemical and Biophysical Research Communications·M HayakawaT Ozawa
Apr 19, 1990·The New England Journal of Medicine·M C DalakasJ L Griffin
Jun 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·C G FragaB N Ames
Nov 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·P A FurmanH Mitsuya
Sep 14, 1989·The New England Journal of Medicine·R YarchoanS Broder
Jan 1, 1985·Annual Review of Nutrition·A Sevanian, P Hochstein
Jan 1, 1988·Annual Review of Cell Biology·L B Chen
Sep 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·C RichterB N Ames
Jan 1, 1985·Molecular Aspects of Medicine·B Halliwell, J M Gutteridge
Oct 1, 1981·Cell·M J BibbD A Clayton
Sep 7, 1995·The New England Journal of Medicine·D R Johns
Apr 1, 1995·Free Radical Biology & Medicine·R K BrownF J Kelly
Sep 13, 1994·Proceedings of the National Academy of Sciences of the United States of America·R Luft
Sep 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·B N AmesT M Hagen
Apr 16, 1996·Proceedings of the National Academy of Sciences of the United States of America·M LevineL R Cantilena
Nov 1, 1996·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·J SastreJ Viña

❮ Previous
Next ❯

Citations

Jun 17, 2008·European Journal of Nutrition·Steffen LoftRyszard Olinski
Dec 15, 2010·Biogerontology·Consuelo BorrásJose Viña
Jun 2, 2009·Cardiovascular Toxicology·I Tong MakWilliam B Weglicki
Sep 3, 2004·Mutation Research·Mark D EvansMarcus S Cooke
Aug 2, 2003·Archives of Biochemistry and Biophysics·Takuya IwamotoShosuke Kawanishi
Apr 11, 2001·Mutation Research·C D Berdanier, H B Everts
Feb 16, 2000·Obstetrics and Gynecology·M T RaijmakersW H Peters
Jun 25, 2002·Molecular Aspects of Medicine·Helen R GriffithsSiân B Astley
Jul 13, 2001·Antiviral Research·R G JainJ M Lenhard
Jun 24, 2003·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·O LopezF Bricaire
Jun 5, 2003·The Lancet Infectious Diseases·Anthony Emmanuel O OgedegbeAnna Mae Diehl
Oct 30, 2001·The Proceedings of the Nutrition Society·C M Pond
Mar 27, 2009·The Journal of Antimicrobial Chemotherapy·Mariana GerschensonRobert L Murphy
May 2, 2007·Antimicrobial Agents and Chemotherapy·Kaleb C LundKendall B Wallace
Aug 17, 2002·Antimicrobial Agents and Chemotherapy·Sabine FranckeLawrence E Mathes
Nov 4, 2009·Journal of Biomedicine & Biotechnology·Antonella MandasNicoletta Curreli
Jan 1, 2012·International Journal of Bioscience, Biochemistry, Bioinformatics (IJBBB)·Dong-Ho ShinMarianna K Baum
Dec 18, 2013·Laboratory Investigation; a Journal of Technical Methods and Pathology·Rebecca A Torres, William Lewis
Dec 12, 2003·Archives of Physical Medicine and Rehabilitation·W Todd CadeRandall E Keyser
Jan 18, 2012·Expert Opinion on Drug Metabolism & Toxicology·Claudia V PereiraYvonne Will
Sep 7, 2011·Drug Metabolism Reviews·Dominique PessayreAbdellah Mansouri
Apr 14, 2006·Expert Opinion on Drug Safety·Nils Venhoff, Ulrich A Walker
Jul 25, 2003·Expert Opinion on Pharmacotherapy·Vicenç FalcóEsteban Ribera
Oct 12, 2010·Expert Opinion on Drug Metabolism & Toxicology·Christopher A Koczor, William Lewis
Feb 9, 2002·Molecular Reproduction and Development·Juan J TarínAntonio Cano
Mar 3, 1999·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·J G de la AsunciónJ Viña
Nov 1, 2009·Environmental Toxicology and Pharmacology·Anna S BelloniSergio Bova
Feb 1, 2006·Revue neurologique·Y GérardY Yazdanpanah
Feb 6, 2008·The Veterinary Clinics of North America. Small Animal Practice·Ling GaoHua Cai
Jun 30, 2004·Diabetes & Metabolism·B FromentyD Pessayre
Oct 27, 2004·Life Sciences·José García de la AsunciónJosé Viña

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.